Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
923 participants
OBSERVATIONAL
2023-04-15
2023-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: This single center retrospective study was performed in an academic hospital. TP-PB were introduced in 2019 and implemented as the main technique by late 2020. To compare the two techniques, data was collected for freehand TR-PB with AP between 2017-2018 and freehand TP-PB without AP between 2021-2022. The data from 2019 and 2020 were excluded to rule out the effects of the initial learning curve during the transition period. Primary outcome measure was post-biopsy complications occurring within 2 weeks, focusing on infectious complications. Secondary outcome measures were detection rates and upgrading/reclassification in the repeat biopsy in active surveillance (AS). Statistical analysis was performed using a Fisher exact or Chi-Squared test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transperineal, MRI-guided, Prostate Biopsy
NCT02651948
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658
US/MRI Fusion Local Anestesia TransPerineal Prostate Biopsies for Detection of Prostate Cancer
NCT04797078
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications
NCT04081636
Infective Complications in TP Biopsy Without Antibiotic Prophylaxis
NCT06359964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transrectal biopsy
prostate biopsy
Prostate biopsy by either transrectal or transperineal technique
transperineal biopsy
prostate biopsy
Prostate biopsy by either transrectal or transperineal technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prostate biopsy
Prostate biopsy by either transrectal or transperineal technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men who underwent prostate biopsy between 2012-2022 (transperineal)
Exclusion Criteria
* patients in the transrectal biopsy group who did not take the prescribed course of antibiotic prophylaxis
* incomplete medical dossier where the occurrence of a complication could not be assessed
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUMC-Pbx23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.